Alternative anticonvulsant drugs for dogs with seizure disorders - Veterinary Medicine
Medicine Center
DVM Veterinary Medicine Featuring Information from:


Alternative anticonvulsant drugs for dogs with seizure disorders
People with seizure disorders have many drug options, but are there safe and effective alternatives to phenobarbital and bromide in dogs? These clinicians share their knowledge of the most promising new drugs.


16. Dayrell-Hart, B. et al.: Efficacy and safety of felbamate as an anticonvulsant in dogs with refractory seizures (abst.). J. Vet. Intern. Med. 10 (3):174; 1996.

17. Johannessen, S.I. et al.: Therapeutic drug monitoring of the newer antiepileptic drugs. Ther. Drug Monit. 25 (3):347-363; 2003.

18. Bazil, C.W.: New antiepileptic drugs. Neurologist 8 (2):71-81; 2002.

19. Ruehlmann, D. et al.: Treatment of partial seizures and seizure-like activity with felbamate in six dogs. J. Small Anim. Pract. 42 (8):403-408; 2001.

20. Radulovic, L.L. et al.: Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Drug Metab. Dispos. 23 (4):441-448; 1995.

21. Vollmer, K.O. et al.: Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Drug Res. 36 (5):830-839; 1986.

22. Leppik, I.E.: The place of levetiracetam in the treatment of epilepsy. Epilepsia 42 (suppl. 4):44-45; 2001.

23. Hovinga, C.A.: Levetiracetam: A novel antiepileptic drug. Pharmacotherapy 21 (11):1375-1388; 2001.

24. Shorvon, S.D.; van Rijckevorsel, K.: A new antiepileptic drug (editorial). J. Neurol. Neurosurg. Psychiatry 72 (4):426-429; 2002.

25. Krakow, K. et al.: Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology 56 (12):1772-1774; 2001.

26. Morrell, M.J. et al.: The KEEPER trial: Levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study. Epilepsy Res. 54 (2-3):153-161; 2003.

27. Isoherranen, N. et al.: Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs. Epilepsia 42 (7):825-830; 2001.

28. Steinberg, M.; Faissler, D.: Levetiracetam therapy for long-term idiopathic epileptic dogs (abst.). J. Vet. Intern. Med. 18 (3):410; 2004.

29. Oommen, K.J.; Mathews, S.: Zonisamide: A new antiepileptic drug. Clin. Neuropharmacol. 22 (4):192-200; 1999.

30. Leppik, I.E.: Zonisamide. Epilepsia 40 (suppl. 5):S23-S29; 1999.

31. Mori, A. et al.: The anticonvulsant zonisamide scavenges free radicals. Epilepsy Res. 30 (2):153-158; 1998.

32. Faught, E. et al.: Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 57 (10):1774-1779; 2001.

33. Leppik, I.E. et al.: Efficacy and safety of zonisamide: Results of a multicenter study. Epilepsy Res. 14 (2):165-173; 1993.

34. Matsumoto, K. et al.: Absorption, distribution and excretion of 3-(sulfamoyl [14C] methyl)-1,2-benzisoxazole (AD-810) in rats, dogs and monkeys and of AD-810 in men. Drug Res. 33 (7):961-968; 1983.

35. Shinoda, M. et al.: The necessity of adjusting the dosage of zonisamide when coadministered with other antiepileptic drugs. Biol. Pharm. Bull. 19 (8):1090-1092; 1996.

36. Dewey, C.W. et al.: Zonisamide therapy for refractory idiopathic epilepsy in dogs. JAAHA 40 (4):285-291; 2004.

37. Walker, R.M. et al.: Chronic toxicity of the anticonvulsant zonisamide in beagle dogs. Fundam. Appl. Toxicol. 11 (2):333-342; 1988.

38. Schicht, S. et al.: Pharmacokinetics of oxcarbazepine in the dog. J. Vet. Pharmacol. Ther. 19 (1):27-31; 1996.

39. Reddy, D.S.: Tiagabine: A potent antiepileptic drug with selective GABA uptake inhibitory effect. Indian J. Pharmacol. 30:141-151; 1998.

40. Streeter, A.J. et al.: Pharmacokinetics and bioavailability of topiramate in the beagle dog. Drug Metab. Dispos. 23 (1):90-93; 1995.


Click here